Gain Therapeutics raised €2.5M in a Series A round in Jan 2019. The company is based in Lugano, Switzerland. Investors in the round: Helsinn Investment Fund, Triventures, VitaTech S.A. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €2.5M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
